Mitragynine in Trinidad and Tobago: not individually verified
We have not confirmed that Mitragynine specifically is scheduled in Trinidad and Tobago, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.
- What is on record
- Not confirmed. No row in the 2016 consolidation's First, Second and Fourth Schedules and the Orders LN 343/2019, LN 345/2019, LN 346/2019, LN 166/2023, LN 131/2024 and LN 293/2026 names mitragynine, and none names 7 hydroxymitragynine; Act No. 24 of 2019 does not name it either. The Second Schedule's three tables list named rows, and the closing lines LN 345/2019 added reach only the salts and stereoisomers of a substance already listed, so they cannot bring in a compound that has no row. The First Schedule's last item, «Other chemical compounds:», names five substances and mitragynine is not among them. The substance is not listed by name in any Schedule read, as at 3 October 2026, the date the instruments were read.
Confirm directly with Trinidad and Tobago’s national drug authority or your own embassy before you rely on anything.
This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
